Nour Al-Mozain: The Evolving Role of Apheresis Across Clinical Practice
Nour Al-Mozain, Hemopathologist, Consultant at King Faisal Specialist Hospital and Research Center, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in CA, adding:
“Our latest publication from American Society for Apheresis , Attending Physician Subcommittee: An Annual Review of Important Apheresis Articles in 2025, published in the CA.
ECP in lung transplantation was among the most exciting themes highlighted in this year’s review, with emerging evidence suggesting a shift toward earlier, prophylactic use to prevent rejection and improve graft survival.
Two randomized studies highlighted the potential of ECP as a prophylactic strategy, rather than solely a treatment for established rejection.
One study demonstrated significant reductions in acute rejection, CLAD, serious infections, and overall AEs when ECP was added to standard immunosuppression.
Another trial in cystic fibrosis lung transplant recipients showed that induction ECP was safe, feasible, and associated with favorable immunologic changes and improved lung function.
Other important studies featured in the review included:
- Multidisciplinary TTP pathways that dramatically reduced relapse and mortality
- Long-term lipoprotein apheresis data showing sustained cardiovascular benefit over 12 years
- Use of peripheral arterial line in pediatric plasma exchange that may reduce the need for central venous access
- Randomized evidence helping define the role—and limitations—of plasma exchange in Long COVID and ANCA-associated vasculitis”
Titles: An Annual Review of Important Apheresis Articles in 2024 From the American Society for Apheresis Attending Physician Subcommittee
Authors: Wen Lu, Laura Dilly, Marisa C. Saint Martin, Nicole D. Zantek, Nour Almozain, Mohamed Alsammak, Grace Banez-Sese, Vishesh Chhibber, Victoria Costa, Phillip J. DeChristopher, Ivan Durlen, Gaurav K. Gupta, Yosef Levenbrown, Yanhua Li, Adela D. Mattiazzi, Daniel K. Noland, Vipulkumar Prajapati, Nirupama Singh, Garima Siwach, Parmatma Prasad Tripathi, Ding Wen Wu, Gay Wehrli, Yvette C. Tanhehco

Stay updated on all scientific advances with Hemostasis Today.
-
Jun 13, 2026, 16:45Sarah Hendry: A Big Day for Gene Therapy Research at EHA 2026
-
Jun 13, 2026, 16:43Akshat Jain: Bridging Innovation and Access in Hematology at EHGCON 2026
-
Jun 13, 2026, 16:21Alvaro Herrera Pérez: Connecting Science and Care at EHA 2026
-
Jun 13, 2026, 16:07Isabelle Mahé: Connecting Expertise in Antithrombotic Care at ISTH 2026
-
Jun 13, 2026, 16:02Tarun Aurora։ Towards Better Risk Stratification in Sickle Cell Disease
-
Jun 13, 2026, 15:59Irene Cuppari: Whole Blood and Component Therapy in Traumatic Hemorrhage
-
Jun 13, 2026, 15:39Ritu Verma: Recognizing Deep Vein Thrombosis Before Complications Arise
-
Jun 13, 2026, 15:09Akshat Jain: Does Mitapivat Translate to Clinical Benefit in SCD?
-
Jun 13, 2026, 14:58Olga Benítez Hidalgo: New Evidence on Marstacimab in Hemophilia Care